The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Bernhard Lüscher sits on this spectrum.
This scientist: 307 publications — 79th percentile
79% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Bernhard Lüscher sits on this spectrum.
This scientist: 99 D-Index — 92nd percentile
92% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Bernhard Lüscher is affiliated with RWTH Aachen University in Germany, contributing extensively to the fields of neuroscience, biochemistry, genetics, molecular biology, and medicine. Their research focuses on molecular biology, biological psychiatry, cellular and molecular neuroscience, and behavioral neuroscience, among other subfields.
Their recent work covers various topics including tryptophan and brain disorders, neuroscience and neuropharmacology research, stress responses and cortisol, nicotinic acetylcholine receptors, pregnancy and preeclampsia studies, gestational diabetes research and management, and neuroendocrine regulation and behavior.
Bernhard Lüscher has published notable papers such as:
They have collaborated frequently with coauthors including Uwe Rudolph, Mengyang Feng, Delia Belelli, Tim G. Hales, and Jeremy J. Lambert. Publication venues commonly featuring their work include the IUPHAR/BPS Guide to Pharmacology CITE, Cells, Molecular Psychiatry, bioRxiv (Cold Spring Harbor Laboratory), and Trends in Pharmacological Sciences.
The scope of Lüscher's studies integrates biological psychiatry and molecular neuroscience, often exploring complex mechanisms underlying affective and cognitive disorders. Their research emphasizes neuropharmacological targets such as GABAA receptors and inhibitory pathways relevant to depression and ketamine's antidepressant effects.
Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif
Marie Henriksson;Bernhard Lüscher
Michael O. Hottiger;Paul O. Hassa;Bernhard Lüscher;Herwig Schüler
Bernhard Luscher;Qiuying Shen;Nadia Sahir
Florence Crestani;Matthias Lorez;Kristin Baer;Christian Essrich
T Williams;A Admon;B Lüscher;R Tjian
B Lüscher;R N Eisenman
Juan Song;Chun Zhong;Michael A. Bonaguidi;Gerald J. Sun
E M Blackwood;B Lüscher;R N Eisenman
Uwe Gunther;Jack Benson;Dietmar Benke;Jean-Marc Fritschy
Ernesto Guccione;Christian Bassi;Fabio Casadio;Francesca Martinato
Bernhard Luscher;Thomas Fuchs;Casey L. Kilpatrick
H Lue;M Thiele;J Franz;E Dahl
Caroline Bouchard;Oliver Dittrich;Astrid Kiermaier;Karen Dohmann
Bernhard Lüscher;Erik Christenson;David W. Litchfield;Edwin G. Krebs
Henning Kleine;Elzbieta Poreba;Krzysztof Lesniewicz;Paul O. Hassa
Karin M. Rothgiesser;Süheda Erener;Susanne Waibel;Bernhard Lüscher
Y. F. Hu;Bernhard Luscher;A. Admon;N. Mermod
Bernhard Lüscher;Cheryl A Keller
B Lüscher;E A Kuenzel;E G Krebs;R N Eisenman
If you think any of the details on this page are incorrect, let us know.
University of Jinan
Yale University
University of Colorado Boulder
Covalent Bioscience
National Chung Hsing University
McMaster University
University of Michigan–Ann Arbor
University of Hong Kong
Microsoft (United States)
Stockholm University
University of Wisconsin–Madison
Northwestern University
Lund University
National University of Kyiv Mohyla Academy
Barnard College
University of Konstanz
